Symphony Financial, Ltd. Co. Amgen Inc Transaction History

Symphony Financial, Ltd. Co.

$608 Million
Q3 2024

A detailed history of Symphony Financial, Ltd. Co. transactions in Amgen Inc stock. As of the latest transaction made, Symphony Financial, Ltd. Co. holds 8,559 shares of AMGN stock, worth $2.4 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

8,559

Previous 8,823 2.99%

Holding current value

$2.4 Million

Previous $2.76 Million 0.04%

% of portfolio

0.45%

Previous 0.51%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$309.38 - $337.38 $81,676 - $89,068	-264 Reduced 2.99%	8,559 $2.76 Million
Q2 2024 Jul 17, 2024	BUY	$262.75 - $319.31 $147,928 - $179,771	563 Added 6.82%	8,823 $2.76 Million
Q1 2024 Apr 17, 2024	BUY	$268.87 - $324.56 $74,476 - $89,903	277 Added 3.47%	8,260 $2.35 Million
Q4 2023 Jan 18, 2024	BUY	$255.7 - $288.46 $2.04 Million - $2.3 Million	7,983 New	7,983 $2.3 Million
Q2 2023 Jul 12, 2023	SELL	$214.27 - $253.37 $446,110 - $527,516	-2,082 Reduced 39.82%	3,147 $698,000
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $351,780 - $428,761	1,558 Added 42.44%	5,229 $1.26 Million
Q4 2022 Jan 26, 2023	BUY	$229.03 - $291.01 $356,370 - $452,811	1,556 Added 73.57%	3,671 $0
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $224 - $253	1 Added 0.05%	2,115 $483,000
Q2 2022 Jul 18, 2022	BUY	$230.71 - $256.74 $11,996 - $13,350	52 Added 2.52%	2,114 $519,000
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $452,134 - $500,179	2,062 New	2,062 $519,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Symphony Financial, Ltd. Co., based on Form 13F filings with the SEC.

News

Stay updated on Symphony Financial, Ltd. Co. with notifications on news.

Account

Symphony Financial, Ltd. Co. Amgen Inc Transaction History